HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Caigang Zhu Selected Research

tetramethyl rhodamine ethyl ester

1/2019Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.
1/2018Metaboloptics: Visualization of the tumor functional landscape via metabolic and vascular imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Caigang Zhu Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 10/2017
4Breast Neoplasms (Breast Cancer)
04/2021 - 01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2022
1Triple Negative Breast Neoplasms
01/2021
1Neoplasm Metastasis (Metastasis)
07/2018
1Carcinogenesis
09/2016

Drug/Important Bio-Agent (IBA)

6Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2017
3Fluorescent Dyes (Fluorescent Probes)IBA
01/2021 - 07/2018
2tetramethyl rhodamine ethyl esterIBA
01/2019 - 01/2018
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2019 - 07/2018
2Oxygen (Dioxygen)IBA
01/2019 - 01/2018
2Matrix Metalloproteinases (MMPs)IBA
07/2018 - 01/2018
1Proteins (Proteins, Gene)FDA Link
01/2022
1Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2021
1Biomarkers (Surrogate Marker)IBA
04/2021
1Perphenazine (Trilafon)FDA LinkGeneric
01/2021
14,4- difluoro- 5,7- dimethyl- 4- bora- 3a,4a- diaza- s- indacene- 3- hexadecanoic acidIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1LipidsIBA
01/2021
1PalmitatesIBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2019
1tetramethylrhodamine (T 489)IBA
07/2018
1EstersIBA
07/2018
16- deoxy- N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)aminoglucose (NBDG)IBA
07/2018
1CarcinogensIBA
09/2016

Therapy/Procedure

2Therapeutics
01/2019 - 07/2018
1Aftercare (After-Treatment)
01/2021